Tóm tắt

Lung cancer is the second most commonly diagnosed cancer and remains the leading cause of cancer deaths worldwide. This is often due to lung cancer first presenting at late stages and a lack of curative therapeutic options at these later stages. Radiography and sputum cytology as the screening modalities to early diagnosis of lung cancer but low sensitivity. Advances in the knowledge of the biology of lung cancer have revealed molecular information used for early diagnosis, with an important impact on patients overall survival and quality of life. The recent years, many new techniques are applied in early diagnosis of lung cancer such as: new imaging techniques, advanced bronchoscopy, liquid biopsy. There technologies used and their potential use for non-invasive screening, early diagnosis, prognosis, response to treatment and real time monitoring of the disease, in lung cancer patients. * Keywords: Lung cancer; Non-small cell lung cancer; New bronchoscopy; Liquid biopsy; Advances in diagnosis.

Abstract

Lung cancer is the second most commonly diagnosed cancer and remains the leading cause of cancer deaths worldwide. This is often due to lung cancer first presenting at late stages and a lack of curative therapeutic options at these later stages. Radiography and sputum cytology as the screening modalities to early diagnosis of lung cancer but low sensitivity. Advances in the knowledge of the biology of lung cancer have revealed molecular information used for early diagnosis, with an important impact on patients overall survival and quality of life. The recent years, many new techniques are applied in early diagnosis of lung cancer such as: new imaging techniques, advanced bronchoscopy, liquid biopsy. There technologies used and their potential use for non-invasive screening, early diagnosis, prognosis, response to treatment and real time monitoring of the disease, in lung cancer patients. * Keywords: Lung cancer; Non-small cell lung cancer; New bronchoscopy; Liquid biopsy; Advances in diagnosis.